drugset / Trial / NCT01848899
Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography
RandomizedParallel-groupSingle-blind
Summary
The aim of this study is to determine how two different types of iodinated contrast media (CM) agents, low-osmolar ionic ioxaglate and iso-osmolar non-ionic iodixanol, affect specific markers of thrombogenesis and platelet function in patients undergoing coronary angiography, and if the use of bivalirudin, a direct thrombin inhibitor used during percutaneous coronary intervention (PCI), affects any contrast-related changes in thrombogenesis and platelet function.
Timeline
- Start
- 2013-02
- Primary completion
- 2013-11
- Completion
- 2014-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iodixanol | Diagnostic / imaging agent | — | — |
| Subject | Ioxaglate | Diagnostic / imaging agent | — | — |
| Background | Bivalirudin | Peptide | — | — |